Differing Standards for the NIH Stem Cell Registry and FDA Approval Render Most Federally Funded hESC Lines Unsuitable for Clinical Use
Year: 2014
Type: article
Source: Cell stem cell
Author: Erica C. Jonlin
Institution: University of Washington
Language: English
Subfield: Issues, ethics and legal aspects
Field: Nursing
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2071197860
